Baker Biotech Capital (GP), LLC Insider Trading $GHDX GENOMIC HEALTH INC
Get free email notifications about insider trading for Baker Biotech Capital (GP), LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Baker Biotech Capital (GP), LLC. Baker Biotech Capital (GP), LLC is 10% Owner in BIOCRYST PHARMACEUTICALS INC ($BCRX) and Director in INCYTE CORP ($INCY) and Director in NEUROGEN CORP ($NRGN) and 10% Owner in IDERA PHARMACEUTICALS, INC. ($IDRA) and 10% Owner in PHARMACYCLICS INC ($PCYC) and 10% Owner in VIROPHARMA INC ($VPHM) and 10% Owner in ADOLOR CORP ($ADLR) and 10% Owner in ALLOS THERAPEUTICS INC ($ALTH) and 10% Owner in Ardea Biosciences, Inc./DE ($IBPI) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in GENOMIC HEALTH INC ($GHDX) and 10% Owner in AUXILIUM PHARMACEUTICALS INC ($AUXL).
Baker Biotech Capital (GP), LLC in GENOMIC HEALTH INC
Trading Symbol: GHDXIndustry: SERVICES-MEDICAL LABORATORIES [8071]
Position of Baker Biotech Capital (GP), LLC: Director
Holdings: 1,253,653 shares
Current Value: $34,462,921
Latest Transaction: Aug 17 2009
$GHDX Market Capitalization: $928.37M
$GHDX Previous Close: $27.49
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Baker Biotech Capital (GP), LLC in GENOMIC HEALTH INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADLR, ALTH, IBPI, AUXL, BCRX, GHDX, IDRA, INCY, NRGN, PCYC, SGEN, VPHM
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 17 2009 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 19.60 | 343 | 6,723 | 1,253,653 | 1.3 M to 1.3 M (+0.03 %) |
Aug 17 2009 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 19.99 | 11,314 | 226,162 | 1,253,310 | 1.2 M to 1.3 M (+0.91 %) |
Aug 12 2009 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 19.70 | 4,690 | 92,378 | 1,241,996 | 1.2 M to 1.2 M (+0.38 %) |
Aug 12 2009 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 19.36 | 1,858 | 35,968 | 1,237,306 | 1.2 M to 1.2 M (+0.15 %) |
Aug 12 2009 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 19.47 | 44 | 857 | 1,235,448 | 1.2 M to 1.2 M (0.00 %) |
Aug 12 2009 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 19.37 | 5,623 | 108,893 | 1,235,404 | 1.2 M to 1.2 M (+0.46 %) |
Aug 12 2009 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 19.48 | 1,454 | 28,323 | 1,229,781 | 1.2 M to 1.2 M (+0.12 %) |
Aug 12 2009 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 19.50 | 2,208 | 43,055 | 1,228,327 | 1.2 M to 1.2 M (+0.18 %) |
Jun 09 2008 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 19.64 | 131 | 2,573 | 1,226,119 | 1.2 M to 1.2 M (+0.01 %) |
Jun 09 2008 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 19.61 | 168 | 3,295 | 1,225,988 | 1.2 M to 1.2 M (+0.01 %) |
Jun 09 2008 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 19.66 | 6,849 | 134,628 | 1,225,820 | 1.2 M to 1.2 M (+0.56 %) |
Jun 09 2008 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 19.67 | 8,271 | 162,653 | 1,218,971 | 1.2 M to 1.2 M (+0.68 %) |
Jun 09 2008 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 20.21 | 36,554 | 738,742 | 1,210,700 | 1.2 M to 1.2 M (+3.11 %) |
Jun 09 2008 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 20.01 | 1,103 | 22,071 | 1,174,146 | 1.2 M to 1.2 M (+0.09 %) |
Jun 09 2008 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 19.61 | 22,883 | 448,697 | 1,173,043 | 1.2 M to 1.2 M (+1.99 %) |
Jun 09 2008 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 19.50 | 56 | 1,092 | 1,150,160 | 1.2 M to 1.2 M (0.00 %) |
May 30 2007 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 16.46 | 933 | 15,361 | 1,150,104 | 1.1 M to 1.2 M (+0.08 %) |
May 30 2007 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 16.44 | 4,051 | 66,592 | 1,149,171 | 1.1 M to 1.1 M (+0.35 %) |
May 30 2007 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 16.39 | 34,288 | 561,850 | 1,145,120 | 1.1 M to 1.1 M (+3.09 %) |
May 30 2007 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 16.24 | 41,909 | 680,782 | 1,110,832 | 1.1 M to 1.1 M (+3.92 %) |
May 24 2007 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 16.35 | 20,175 | 329,912 | 1,068,923 | 1 M to 1.1 M (+1.92 %) |
May 24 2007 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 16.31 | 4,480 | 73,072 | 1,048,748 | 1 M to 1 M (+0.43 %) |
May 24 2007 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 16.40 | 26,373 | 432,557 | 1,044,268 | 1 M to 1 M (+2.59 %) |
May 24 2007 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 16.67 | 142,938 | 2,382,705 | 1,017,895 | 875 K to 1 M (+16.34 %) |
May 22 2007 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 15.50 | 268,248 | 4,157,844 | 874,957 | 606.7 K to 875 K (+44.21 %) |
Mar 13 2007 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 18.28 | 62,321 | 1,139,284 | 606,709 | 544.4 K to 606.7 K (+11.45 %) |
Mar 13 2007 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 18.44 | 4 | 74 | 544,388 | 544.4 K to 544.4 K (0.00 %) |
Mar 05 2007 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 18.02 | 2,812 | 50,684 | 544,384 | 541.6 K to 544.4 K (+0.52 %) |
Mar 05 2007 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 17.77 | 3,899 | 69,285 | 541,572 | 537.7 K to 541.6 K (+0.73 %) |
Mar 05 2007 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 17.90 | 80 | 1,432 | 537,673 | 537.6 K to 537.7 K (+0.01 %) |
Mar 05 2007 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 18.20 | 13,004 | 236,726 | 537,593 | 524.6 K to 537.6 K (+2.48 %) |
Feb 21 2007 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 18.54 | 9,184 | 170,301 | 524,589 | 515.4 K to 524.6 K (+1.78 %) |
Feb 21 2007 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 18.43 | 212 | 3,907 | 515,405 | 515.2 K to 515.4 K (+0.04 %) |
Feb 14 2007 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 18.36 | 25,957 | 476,571 | 515,193 | 489.2 K to 515.2 K (+5.31 %) |
Feb 14 2007 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 18.43 | 52 | 958 | 489,236 | 489.2 K to 489.2 K (+0.01 %) |
Feb 14 2007 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 18.26 | 61,735 | 1,127,127 | 489,184 | 427.4 K to 489.2 K (+14.44 %) |
Feb 14 2007 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 17.89 | 8,039 | 143,838 | 427,449 | 419.4 K to 427.4 K (+1.92 %) |
Dec 08 2006 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 21.58 | 12,237 | 264,103 | 419,410 | 407.2 K to 419.4 K (+3.01 %) |
Dec 05 2006 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 22.55 | 25,071 | 565,256 | 407,173 | 382.1 K to 407.2 K (+6.56 %) |
Dec 05 2006 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 20.78 | 8,644 | 179,613 | 382,102 | 373.5 K to 382.1 K (+2.31 %) |
Dec 05 2006 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 20.38 | 3,336 | 68,004 | 373,458 | 370.1 K to 373.5 K (+0.90 %) |
Dec 05 2006 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 19.00 | 16,512 | 313,728 | 370,122 | 353.6 K to 370.1 K (+4.67 %) |
Dec 05 2006 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 20.79 | 5,828 | 121,158 | 353,610 | 347.8 K to 353.6 K (+1.68 %) |
Dec 05 2006 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 18.95 | 1,194 | 22,628 | 347,782 | 346.6 K to 347.8 K (+0.34 %) |
Dec 05 2006 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 18.99 | 1,093 | 20,754 | 346,588 | 345.5 K to 346.6 K (+0.32 %) |
Dec 05 2006 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 20.41 | 111,763 | 2,281,150 | 345,495 | 233.7 K to 345.5 K (+47.82 %) |
Page: 1